Clinical
Gastrointestinal Viral Infections
Last reviewed 7 July 2026
Gastroenteritis, inflammation of the stomach and intestine, is one of the commonest illnesses of infants, children and adults, and much of it is viral. The clinical picture ranges from pure vomiting (the old “winter vomiting disease”) through abdominal cramping, anorexia, nausea and malaise to profuse watery diarrhoea, and the different viral agents produce a picture that is essentially indistinguishable at the bedside. Worldwide the syndrome still causes over 500,000 deaths a year in children under five, almost all in low- and middle-income countries, and the killing mechanism is simple: loss of fluid and electrolytes faster than they can be replaced.
What organises the field is not the individual virus but two epidemiological patterns, endemic childhood disease and epidemic outbreaks, and the single clinical task that matters most, judging and correcting dehydration.
The viruses and their families
Four families account for the proven causes of acute viral gastroenteritis. Knowing the family predicts the genome, the environmental stability and the epidemiological behaviour.
| Virus | Family / genome | Morphology | Main setting |
|---|---|---|---|
| Rotavirus (group A) | Reoviridae, 11-segment dsRNA | 70 nm double-shelled wheel | Endemic severe childhood diarrhoea |
| Norovirus | Caliciviridae, ssRNA | 27 to 32 nm, feathery edge | Outbreaks and endemic disease, all ages |
| Sapovirus | Caliciviridae, ssRNA | Star-of-David cup morphology | Endemic childhood diarrhoea |
| Astrovirus | Astroviridae, ssRNA | 28 nm, five- or six-pointed star | Endemic childhood diarrhoea |
| Enteric adenovirus (types 40, 41) | Adenoviridae, dsDNA | 70 nm icosahedral, non-enveloped | Endemic childhood diarrhoea |
All are non-enveloped, which makes them robust in the environment and resistant to many disinfectants and to alcohol hand rubs, and all spread chiefly by the faecal-oral route. Their history is a history of detection methods: the Norwalk agent was the first virus clearly shown to cause diarrhoea, visualised by Kapikian in 1972 using immune electron microscopy, and rotavirus followed in 1973 when Bishop and colleagues saw it in duodenal biopsies, with the enteric adenoviruses (serotypes 40 and 41, group F) and astroviruses recognised soon after.
The amount of virus shed varies enormously, from about a trillion particles per gram of stool for rotavirus down to sub-detectable levels for norovirus, which is why rotavirus was understood first and norovirus only after molecular tests arrived. Although each family has animal counterparts, transmission between animals and humans is minimal or absent.
Rotavirus is globally the most important cause of severe diarrhoea in young children. Where rotavirus vaccination is mature, norovirus has often overtaken it as the leading cause of paediatric gastroenteritis. Enteric adenoviruses and astroviruses each account for roughly 5% to 10% of medically attended childhood episodes. Group B and group C rotaviruses cause outbreaks rather than endemic childhood disease, group B producing a cholera-like, water-borne illness in adults described mainly in China.
Several further agents (toroviruses, picobirnaviruses, Aichi virus, parechoviruses, the enteric coronaviruses) are found in stool but have not met the criteria for causation and are considered separately below.
Two epidemiological patterns
Viral gastroenteritis occurs in two contrasting settings, and separating them guides both diagnosis and control.
| Feature | Endemic childhood diarrhoea | Epidemic outbreaks |
|---|---|---|
| Typical agents | Rotavirus A, noroviruses, sapovirus, astrovirus, adenovirus 40/41 | Noroviruses mainly; rotavirus B and C, astrovirus in special settings |
| Age affected | Under 5 years | All ages |
| Immunity | Seroprevalence approaches 100% by age 5 | Variable, with seroconversion in cases |
| Transmission | Faecal-oral, contact, droplet | Person-to-person, food (shellfish), water |
| Control | Rotavirus vaccination | Removing the contaminated vehicle, disinfection, excluding ill people |
The endemic pattern reflects the universal early-childhood exposure that leaves almost every child seropositive by school age. Before vaccination, rotavirus alone caused around 200,000 deaths a year in children under five, more than 85% of them in the poorest countries. Norovirus is estimated to cause about 18% of severe childhood diarrhoea worldwide and, after rotavirus vaccine introduction, has become the commonest cause of medically attended gastroenteritis in children in high-coverage countries.
The epidemic pattern is dominated by norovirus, which needs a tiny inoculum (fewer than 100 particles), is shed in vomitus as well as stool, and survives on surfaces, so it spreads explosively in hospitals, cruise ships, care homes, schools and around contaminated food and water, especially raw shellfish.
The two patterns overlap: rotavirus occasionally causes outbreaks in adults whose immunity has waned or who meet a large inoculum, and norovirus is now recognised as a common cause of endemic childhood diarrhoea.
Susceptibility to norovirus is partly genetic, because the virus attaches to histo-blood-group antigens on the gut mucosa; people with an inactivating mutation of the secretor (FUT2) gene, the nonsecretor phenotype, are relatively resistant to the predominant GII.4 genotype, and a similar influence is emerging for rotavirus.
Who is at risk
Two kinds of risk factor operate, increased exposure and increased susceptibility, and they overlap at the extremes of age.
| Increased exposure | Increased susceptibility |
|---|---|
| Young children and the elderly | Young children and the elderly (absent or waning immunity) |
| Parents and caretakers of infected children | Immunodeficiency: SCID, advanced HIV, chemotherapy, transplantation |
| Hospital wards, day-care, care homes | Secretor (FUT2-positive) status for norovirus |
| Travellers to low-income countries | Malnutrition |
SCID is severe combined immunodeficiency. Institutional settings breach the hygiene that would otherwise interrupt faecal-oral spread, and closed environments amplify outbreaks: viral gastroenteritis has accounted for a large share of acute gastroenteritis in deployed military personnel and causes rapid outbreaks aboard cruise ships and aircraft.
Immunodeficient children and adults are readily infected and shed the viruses for prolonged periods, and may develop severe, chronic diarrhoea. The elderly, particularly when frail, immunocompromised or burdened by diabetes or heart disease, can develop life-threatening dehydration from what would be a trivial illness in a healthy adult.
Pathogenesis
The viruses infect the mature enterocytes of the small-intestinal villi, causing patchy villous shortening and loss of the absorptive surface. The severity of disease is set by the degree and rate of fluid and electrolyte loss and by how quickly it can be replaced. Diarrhoea arises by more than one mechanism. Destruction of absorptive cells reduces uptake of water and salt and leaves undigested carbohydrate in the lumen, producing an osmotic diarrhoea.
Rotavirus adds a secretory component: its non-structural protein NSP4 acts as a viral enterotoxin, raising intracellular calcium and driving chloride and water secretion, which is why inactivated virus can provoke diarrhoea in animal models without tissue invasion. Vomiting is prominent, especially with norovirus, through a mechanism separate from the diarrhoea and poorly understood.
There is no inflammatory destruction of the mucosa of the kind seen in bacterial dysentery, so the stool contains no blood or pus, and this absence is a useful discriminator from invasive bacterial and amoebic causes. Illness is generally brief, lasting three to five days as the epithelium regenerates, though rotavirus diarrhoea often persists for four to eight days. Extraintestinal spread is rare, but rotavirus and norovirus antigen and nucleic acid can be found transiently in blood.
Two features complicate attribution of any detected virus to disease: asymptomatic infection and shedding are common, especially with norovirus, and shedding continues for days to weeks after recovery.
The clinical approach to a child with viral gastroenteritis
The central clinical judgement is not which virus but how dehydrated the child is, because that determines both the risk and the treatment. After an incubation of 12 to 48 hours the child develops watery diarrhoea, usually with vomiting and sometimes low-grade fever, myalgia and malaise. The short incubation is itself useful: it separates viral gastroenteritis from the even shorter illness (under 12 hours) of a preformed bacterial toxin such as that of Staphylococcus aureus or Bacillus cereus, and from the longer course of invasive bacterial enteritis.
Although the agent cannot be identified clinically, the established causes differ in whom they strike and in the timing and prominence of symptoms.
| Agent | Age group | Vomiting | Fever | Incubation | Duration | Note |
|---|---|---|---|---|---|---|
| Rotavirus A | Infants, toddlers | Common | Common | 1 to 3 days | 5 to 7 days | Commonest severe childhood diarrhoea; vaccine-preventable |
| Rotavirus B | Children, adults | Variable | Rare | ~2 days | 3 to 7 days | Cholera-like disease in adults, China |
| Rotavirus C | All ages | Uncertain | Uncertain | 1 to 2 days | 3 to 7 days | Sporadic; rare childhood outbreaks |
| Adenovirus 40/41 | Young children | Common | Common | 7 to 8 days | 8 to 12 days | Endemic; notably long incubation |
| Sapovirus | Infants to adults | Common in infants | Occasional | 1 to 3 days | 1 to 3 days | Endemic in children |
| Norovirus | All ages | Common | Rare or mild | 18 to 48 hours | 12 to 48 hours | Commonest cause of outbreaks |
| Astrovirus | Young children, elderly | Occasional | Occasional | 1 to 4 days | 2 to 3 days | Near-universal in early childhood; usually mild |
Assessment turns on estimating fluid deficit from the physical signs: alertness, thirst, sunken eyes, skin turgor, tears, mucous membranes, capillary refill and urine output. Watery, non-bloody stool with vomiting in a young child points to a viral cause; blood or mucus in the stool, high fever or a toxic child should redirect the search to invasive bacterial pathogens.
The differential of acute diarrhoea includes bacterial and parasitic enteritis, systemic infection presenting with diarrhoea, and, in a young infant, surgical causes such as intussusception. Danger signs prompting closer observation or admission include very young age, drowsiness or marked irritability, intractable vomiting, a progressive course and diagnostic uncertainty.
Other and unproven agents
Beyond the four established families, several viruses are found in stool more often in cases than controls but have not been confirmed as causes of human gastroenteritis. Torovirus is detected mainly in nosocomial and immunocompromised patients and, unusually, is associated with more bloody diarrhoea and less vomiting than rotavirus or astrovirus.
The enteric coronaviruses have an uncertain role, but gastrointestinal involvement by their pathogenic relatives is well documented: more than a third of patients in the SARS outbreak had diarrhoea, sometimes as the presenting symptom, with prolonged faecal shedding, and MERS-CoV is also associated with diarrhoea and faecal viral RNA. Picobirnaviruses, Aichi virus, parechoviruses and pestiviruses remain unconfirmed. In advanced HIV, chronic prolonged diarrhoea has been attributed to the enteric coronaviruses and picobirnaviruses, though pathogenicity is unproven.
Separately, gastroenteritis is increasingly recognised as part of systemic infection by viruses whose primary target lies elsewhere: diarrhoea and vomiting accompany avian and pandemic influenza, Ebola virus disease, and COVID-19, where they reflect systemic illness rather than a primary enteric infection.
Extraintestinal manifestations of the enteric viruses are rare in humans despite the range of systemic disease their relatives cause in animals. Several associations proposed for rotavirus, including Reye syndrome, Kawasaki disease, intussusception with wild-type infection and necrotising enterocolitis, are not established as causal.
The laboratory
For the individual child with typical, self-limited gastroenteritis, specific viral diagnosis rarely changes management, and treatment is started on clinical grounds. Testing is directed instead at outbreak investigation, surveillance and the immunocompromised. Rotavirus is shed in vast numbers and is easily detected by a rapid, sensitive stool enzyme immunoassay, and enteric adenovirus by antigen assay. Reverse-transcription polymerase chain reaction (RT-PCR) is the method of choice for norovirus, detecting as few as ten copies; it also detects sapovirus and astrovirus, and sequencing its product allows genotyping.
Norovirus antigen enzyme immunoassays exist but have low sensitivity and are useful only for confirming the agent across an outbreak, not for excluding it in an individual.
Because RT-PCR is so sensitive, norovirus is frequently found in healthy people, so a positive result is interpreted against the clinical picture and, in outbreaks, the background detection rate. Stool collected within 48 hours of onset gives the highest yield, since shedding is greatest during acute diarrhoea. Electron microscopy needs a high viral load (above roughly a million particles per gram) and misses the sparsely shed agents.
Paired serology is used mainly in outbreak investigation and research rather than individual diagnosis. The laboratory’s population-level role is central to surveillance: tracking circulating rotavirus genotypes, confirming the aetiology of outbreaks by molecular epidemiology, and measuring the impact of vaccination.
Management
No virus-specific therapy exists, and management is supportive, centred on fluid and electrolyte replacement. Low-osmolarity oral rehydration solution (about 245 mOsm/L, adopted by WHO and UNICEF in 2004) is the mainstay, reducing stool output and vomiting compared with the older higher-osmolarity formulation, and is sufficient for most children; breastfed infants continue to nurse, and early refeeding aids recovery.
Intravenous rehydration is reserved for severe dehydration (a fluid deficit of about 10% or more, shock or near-shock), intractable vomiting or failure of oral therapy. Antibiotics have no role in uncomplicated viral gastroenteritis and risk harm; antimotility drugs such as loperamide and diphenoxylate do not reduce fluid loss and are avoided, particularly under three years of age.
Zinc supplementation reduces the severity, duration and incidence of diarrhoea and is a mainstay of paediatric treatment in low- and middle-income settings; evidence for probiotics is conflicting. Immunodeficient children who develop chronic rotavirus diarrhoea need additional nutritional support and have been treated with oral human antirotavirus antibody.
Prevention
For endemic childhood disease, vaccination is the effective intervention; other measures (hand hygiene, safe disposal of faeces, barrier precautions) reduce but do not control transmission. Passive protection also matters: breast milk, and bovine colostrum containing antirotavirus antibody, protect feeding infants.
Two live oral rotavirus vaccines have been in wide use since 2006, the monovalent human vaccine Rotarix and the pentavalent human-bovine reassortant RotaTeq, with further products (including the human-bovine 116E vaccine) licensed since. Large trials showed 85% to 98% efficacy against severe group A rotavirus disease, and their introduction has produced substantial, sustained falls in rotavirus hospitalisations, shifting the paediatric gastroenteritis burden towards norovirus. A small excess risk of intussusception in the days after the first dose has been quantified and is greatly outweighed by the benefit.
There is no licensed vaccine for the other agents, though norovirus virus-like-particle vaccines are in trials. For outbreaks, control rests on identifying and removing the contaminated food or water, disinfection, and excluding ill people; because norovirus resists many agents and needs a minute inoculum, thorough environmental decontamination and handwashing with soap and water (more effective than alcohol rub against this non-enveloped virus) are essential.
South African context
Diarrhoeal disease is an important cause of death in South African children under five. Rotavirus vaccine is part of the childhood Expanded Programme on Immunisation (EPI-SA), given as two oral doses of monovalent Rotarix at 6 and 14 weeks of age, and it should not be started or completed after the recommended upper age limit because of the intussusception consideration. Case management follows the national paediatric standard treatment guidelines: assessment of dehydration, oral rehydration solution and zinc for most children, and intravenous fluids for severe dehydration.
References and recommended reading
- Leshem E, Parashar UD. Gastrointestinal Syndromes. In: Richman DD, Whitley RJ, Hayden FG, editors. Clinical Virology, 4th edition, Chapter 4. Washington: ASM Press; 2016. The backbone source for the enteric viruses, their epidemiology and the clinical approach.
- Burrell CJ, Howard CR, Murphy FA. Fenner and White’s Medical Virology, 5th edition. Academic Press / Elsevier; 2017. The source for the comparative agent and epidemiology tables adapted here.
- National Department of Health. Expanded Programme on Immunisation (EPI-SA): schedule and programme overview. Pretoria: NDoH; 2024. The current South African reference for the rotavirus vaccine schedule.
- National Department of Health. Hospital Level (Paediatric) Standard Treatment Guidelines and Essential Medicines List. Pretoria: NDoH; 2023. The reference for rehydration, zinc and the management of childhood gastroenteritis.